Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.
Patient feedback information is available for physicians employed by Rush University Medical Center who have received
30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.
(If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
I treat the gastrointestinal cancers, which includes colon cancer, stomach cancer, pancreas cancer. We do the medical oncology part and there’s also radiation oncology, surgery. So it’s kind of a combined effort.
There are a lot of different drugs that are available, so patients have better outcomes and we’ve got a lot of long-term survivors. You know, people say, “Isn’t it depressing to treat these cancer patients?” But a lot of people are cured, especially for colon cancer or anal cancer, rectal cancer.
Within 10 to 15 years we’re going to take the patient’s tumor, analyze all the genes in the tumor and make like a designer treatment for that patient. We’re not there yet, but at Rush we’re testing for some of those genes already.